Author Question: When prescribing montelukast (Singulair) for asthma, patients or parents of patients should be ... (Read 29 times)

storky111

  • Hero Member
  • *****
  • Posts: 561
When prescribing montelukast (Singulair) for asthma, patients or parents of patients should be instructed:
 
  1. Montelukast twice a day is started when there is an asthma exacerbation.
  2. Patients may experience weight gain on montelukast.
  3. Aggression, anxiety, depression, and/or suicidal thoughts may occur when taking montelukast.
  4. Lethargy and hypersomnia may occur when taking montelukast.

Question 2

Christy has exercise-induced and mild persistent asthma and is prescribed two puffs of albuterol 15 minutes before exercise and as needed for wheezing. One puff per day of beclomethasone (QVAR) is also prescribed. Teaching regarding her inhalers includes:
 
  1. Use one to two puffs of albuterol per day to prevent an attack with no more than eight puffs per day
  2. Beclomethasone needs to be used every day to treat her asthma
  3. Report any systemic side effects she is experiencing, such as weight gain
  4. Use the albuterol metered-dose inhaler (MDI) immediately after her corticosteroid MDI to facilitate bronchodilation



elizabethrperez

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

3

Answer to Question 2

2



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library